Central Nervous System

Pharma News and Update for Incyte and Aptose

Notizia - Recent Pharma, Healthcare and Biotech Happenings

AstraZeneca’s Farxiga; Incyte’s Jakavi; FDA Fast Track Status to HM43239 for R/R AML; Idorsia’s Insomnia Drug Quviviq; EU Approves Kymirah For Follicular Lymphoma; Perrigo Acquires HRA Pharma; Janssen Submits Marketing Authorisation Application to EMA

AstraZeneca’s Farxiga Meets Primary Endpoints in Phase 3 Heart Failure Trial Farxiga, an SGLT2 inhibitor from AstraZeneca, has shown positive results in a phase 3 Heart Failure trial, putting it back in contention with Jardiance from Boehringer Ingelheim and Eli Lilly. The DELIVER trial's top-line results demonstrated that Farxiga (dapagliflozin) was able to lower the risk of cardiovascular mortality or worsening heart failure in patients with Heart Failure with Preserved Ejection Fraction (HFpEF), paving the way for new indication filings in the coming months. Based on the findings of the DAPA-HF study, Farxiga was the first drug in the class to be licensed to ...

Explore More...

pharma-news-for-biogen-eisai-quidel-accutar-boehringer

Biogen-Eisai’s Aduhelm; Quidel acquires Ortho Clinical Diagnostics; Accutar Biotechnology’s AC0176; Boehringer’s Spesolimab

pharma-news-for-aslan-iqvia-reata-recordati-eusa

Aslan Pharma – IQVIA collaboration; Reata’s kidney drug bardoxolone; Alzheimer’s Disease treatment update; Recordati to acquire EUSA

medtech-news-for-lensgen-ge-nevro-hyperfine-immunexpress

LensGen’s Juvene Intraocular Lens; Nevro announces clinical data publications; FDA Clearance to Immunexpress’s SeptiCyte; GE unveils AI and Digital Technologies; Canon launches PIQE DLR and SilverBeam; Hyperfine’s Swoop gets FDA clearance

medtech-news-for-neurent-theradaptive-hagar-fujifilm-brain-navi

Neurent Medical’s NEUROMARK; Brain Navi NaoTrac received European CE Mark approval; Theradaptive receives Breakthrough Medical Device Designation; HAGAR GWave awarded Breakthrough Device Designation; Fujifilm launches ColoAssist PRO

medtech-news-for-tectraum-vektor-medtronic-alcon-philips-sight-sciences

TecTraum’s pro2cool receives Breakthrough Device Designation; Vektor Obtains FDA Clearance for vMap; Medtronic’s TMVR system; Sight Sciences’s PRECISION Trial; Alcon to buy Ivantis; Philips to acquire Cardiologs

medtech-news-updates-for-renew-bioscience-perimeter-medical-smithnephew-perimeter-medical-imaging-ai-saga-diagnostics-astrazeneca-magnus-medical-revalve-solutions

Smith+Nephew’s LEGION CONCELOC; Renew Bioscience’s Cerezen; Perimeter Medical’s ATLAS AI Project; SAGA Diagnostics-AZ’s Deal; Magnus Receives Breakthrough Device Designation; ReValve’s Transeptal Mitral Valve Replacement

An in-depth Assessment of the Top Drugs Launched by Leading Global Companies in the First Half of 2021 (H1)

recent-pharma-news-for-biogen-phathom-vertex-natera

Biogen’s ALS drug Tofersen (BIIB067); Phathom’s erosive esophagitis drug trial; Vertex’s islet cell therapy; Natera launches lung DNA test

recent-biotech-pharma-news-for-brickell-bms-amydis-gensight-cybrexa

Brickell to Submit New Drug Application to FDA; Twin Health Raises $140M; BMS’ Deucravacitinib; Lando Biopharma’s LABP-104 gets Approval; NIH Grant of $ 3 M to Amydis; FDA Grant to GenSight’ GS030

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional Therapies for Depression

medtech-news-updates-for-iotamotion-recor-natera-boston-scientific

Amber Implants VCFix spinal system; iotaMotion’s iotaSOFT Insertion System; Boston Scientific acquires Baylis; ReCor’s Paradise Ultrasound Renal Denervation; Boston Scientific’s Ranger Drug-Coated Balloon; Natera’s Prospera

medtech-happenings-for-neurolief-paige-bionaut-retina-medtronic

RETINA-AI Health declares positive results; Medtronic’s Hugo robotic-assisted surgery system; Boston Scientific acquires Devoro Medical; Paige obtains first-ever FDA approval

pharma-biotech-news-updates-for-innovent-biohaven-delix-intracellular-therapies

UNION Therapeutics-Innovent’s collaboration; Delix Therapeutics bags $ 70 M; Biohaven’s Verdiperstat clinical trial result; Intra-Cellular’s CAPLYTA Phase III study

pharma-happenings-for-amylyx-beigene-roche-temedic-sage-therapeutics

FDA’s New Drug Application to ALS Drug; Approval to BeiGene’s Brukinsa; Roche, Temedica Forges Digital Companionship, Shares of Sage Therapeutics Rises

pharma-news-and-updates-for-Ascendis-MicroTransponder-BioMarin-Zimmer-Biomet-Canary-Medical

Ascendis’s SKYTROFA; MicroTransponder’s VNS System (Vivistim); BioMarin’s Voxzogo; Zimmer-Canary’s Smart Knee Implant; COVID-19 impact on Solid Organ Transplants

recent-pharma-news-and-updates-for-sanofi-marinus-orion-mestag-moderna

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective